Αποτελέσματα Αναζήτησης
Rarely patients have reported severe bone, joint and muscle pain that begins from 1 day to one month after starting any bisphosphonate, including Zolendronic acid. Most patients report relief from these symptoms after stopping the medication.
5 Μαΐ 2023 · Reclast is a drug that can treat and prevent osteoporosis by reducing bone loss and promoting bone formation. A person receives a reclast infusion via an intravenous infusion (IV) into a vein.
Taken once a year, intravenous zoledronic acid (Zol) (Reclast ® or Aclasta ®) is a third-generation nitrogen-containing bisphosphonate that is effective compared with placebo in reducing the risk of fractures in patients with postmenopausal osteoporosis and recent low-trauma hip fracture.
Zoledronic acid is given once a year as an intravenous (IV) infusion to treat osteoporosis. It is also given every two years as an IV infusion to prevent osteoporosis. Zoledronic acid increases bone density and reduces the incidence of the spine and non-spine fractures, including hip fractures.
You should drink at least 2 glasses of fluid within a few hours before receiving Reclast to reduce the risk of kidney problems. 3. Severe jaw bone problems (osteonecrosis). Severe jaw bone problems may happen when you take Reclast. Your doctor should examine your mouth before you start Reclast.
It works by slowing the breakdown of bone and keeping bones strong. It also helps to reduce the risk of broken bones (fractures). This medication belongs to a class of drugs known as...
15 Αυγ 2008 · Zoledronic acid (Reclast) is a parenteral, once-yearly bisphosphonate labeled for the treatment of osteoporosis in postmenopausal women. Serious adverse effects with zoledronic acid are...
